Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
European Journal of Medicinal Chemistry
|
April 16, 2019
Discovery of (R)-5-((5-(1-methyl-1H-pyrazol-4-yl)-4-(methylamino)pyrimidin-2-yl)amino)-3-(piperidin-3-yloxy)picolinonitrile, a novel CHK1 inhibitor for hematologic malignancies
Lexian Tong, Pinrao Song, Kailong Jiang, et al.
Science Advances
|
June 12, 2026
VMP1 forms a Ca<sup>2+</sup> release channel essential for postnatal heartbeat
Yuying Ma, Qiguang Li, Yuting Jia, et al.
Acta Pharmacologica Sinica
|
July 14, 2025
Discovery of selective GluN1/GluN3A NMDA receptor inhibitors using integrated AI and physics-based approaches
Shi-Wei Li, Yue Zeng, Sa-Nan Wu, et al.
Disease Markers
|
September 19, 2022
Combining Phenotypes of Nucleotide Excision Repair Pathway to Predict the Risk of Head and Neck Squamous Cell Carcinomas in a Chinese Population
Yiqian Liang, Ling Zhang, Zichen Chen, et al.
Acta Pharmacologica Sinica
|
July 23, 2021
Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates
Yi Wang, Sui Fang, Yan Wu, et al.
Acta Pharmacologica Sinica
|
August 13, 2025
Identification of small-molecule inhibitors for GluN1/GluN3A NMDA receptors via a multiscale CNN-based prediction model
Li Han, Yue Zeng, Zhi-Yan Qu, et al.
Journal of Medicinal Chemistry
|
July 22, 2024
Discovery of Novel Pyrimidine-Based Derivatives as Nav1.2 Inhibitors with Efficacy in Mouse Models of Epilepsy
Guoxue He, Yueming Zheng, Shunzhen Chang, et al.
Pediatrics
|
November 12, 2017
Effectiveness of a Kindergarten-Based Intervention for Preventing Childhood Obesity
Yan Hu, Jian-Rong He, Fang-Hua Liu, et al.
The Journal of Antimicrobial Chemotherapy
|
August 2, 2020
Impact of archived M184V/I mutation on the effectiveness of switch to co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide among virally suppressed people living with HIV
Guan-Jhou Chen, Yu-Lin Lee, Chen-Hsiang Lee, et al.
International Journal of Antimicrobial Agents
|
July 5, 2022
Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimens
Guan-Jhou Chen, Hsin-Yun Sun, Ling-Ya Chen, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
European Journal of Medicinal Chemistry
|
April 16, 2019
Discovery of (R)-5-((5-(1-methyl-1H-pyrazol-4-yl)-4-(methylamino)pyrimidin-2-yl)amino)-3-(piperidin-3-yloxy)picolinonitrile, a novel CHK1 inhibitor for hematologic malignancies
Lexian Tong, Pinrao Song, Kailong Jiang, et al.
Science Advances
|
June 12, 2026
VMP1 forms a Ca<sup>2+</sup> release channel essential for postnatal heartbeat
Yuying Ma, Qiguang Li, Yuting Jia, et al.
Acta Pharmacologica Sinica
|
July 14, 2025
Discovery of selective GluN1/GluN3A NMDA receptor inhibitors using integrated AI and physics-based approaches
Shi-Wei Li, Yue Zeng, Sa-Nan Wu, et al.
Disease Markers
|
September 19, 2022
Combining Phenotypes of Nucleotide Excision Repair Pathway to Predict the Risk of Head and Neck Squamous Cell Carcinomas in a Chinese Population
Yiqian Liang, Ling Zhang, Zichen Chen, et al.
Acta Pharmacologica Sinica
|
July 23, 2021
Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates
Yi Wang, Sui Fang, Yan Wu, et al.
Acta Pharmacologica Sinica
|
August 13, 2025
Identification of small-molecule inhibitors for GluN1/GluN3A NMDA receptors via a multiscale CNN-based prediction model
Li Han, Yue Zeng, Zhi-Yan Qu, et al.
Journal of Medicinal Chemistry
|
July 22, 2024
Discovery of Novel Pyrimidine-Based Derivatives as Nav1.2 Inhibitors with Efficacy in Mouse Models of Epilepsy
Guoxue He, Yueming Zheng, Shunzhen Chang, et al.
Pediatrics
|
November 12, 2017
Effectiveness of a Kindergarten-Based Intervention for Preventing Childhood Obesity
Yan Hu, Jian-Rong He, Fang-Hua Liu, et al.
The Journal of Antimicrobial Chemotherapy
|
August 2, 2020
Impact of archived M184V/I mutation on the effectiveness of switch to co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide among virally suppressed people living with HIV
Guan-Jhou Chen, Yu-Lin Lee, Chen-Hsiang Lee, et al.
International Journal of Antimicrobial Agents
|
July 5, 2022
Low-level viraemia and virologic failure among people living with HIV who received maintenance therapy with co-formulated bictegravir, emtricitabine and tenofovir alafenamide versus dolutegravir-based regimens
Guan-Jhou Chen, Hsin-Yun Sun, Ling-Ya Chen, et al.
Page
of 4